A phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
- 1 September 1996
- Vol. 78 (5) , 1085-1088
- https://doi.org/10.1002/(sici)1097-0142(19960901)78:5<1085::aid-cncr19>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Different dose regimens of 5-fluorouracil and interferon-α in patients with metastatic colorectal carcinomaEuropean Journal Of Cancer, 1995
- Interferon-α, 5-FU and prednisone in metastatic renal cell carcinoma: A phase II studyAnnals of Oncology, 1994
- Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferonCancer Chemotherapy and Pharmacology, 1994
- Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancerEuropean Journal Of Cancer, 1993
- Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferonCancer, 1993
- A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinomaInvestigational New Drugs, 1992
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1992
- A dual anti-tumor effect of a combination of interferon-α or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicityClinical Immunology and Immunopathology, 1992
- Interferon effects upon fluorouracil metabolism by HL-60 cellsBiochemical and Biophysical Research Communications, 1989